rxstat › Shortages › Loperamide
Loperamide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Loperamide products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Oct 9, 2014
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-LOPERAMIDE - TAB 2MG
2MG · TABLET · APOTEX INC
DIN 02212005 · since Oct 9, 2014, no end estimate · Disruption of the manufacture of the drug.
ResolvedTEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Jul 20, 2023 · Disruption of the manufacture of the drug.
ResolvedTEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.
ResolvedTEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Jul 22, 2020 · Disruption of the manufacture of the drug.
ResolvedPMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended Feb 6, 2019 · Disruption of the manufacture of the drug.
ResolvedPMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended Jan 16, 2019 · Disruption of the manufacture of the drug.
ResolvedLOPERAMIDE-2
2MG · TABLET · PRO DOC LIMITEE
DIN 02225182 · ended Dec 5, 2018 · Delay in shipping of the drug.
ResolvedTEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended May 10, 2018 · Disruption of the manufacture of the drug.
ResolvedTEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended May 10, 2018 · Disruption of the manufacture of the drug.
ResolvedPMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML
0.2MG · SOLUTION · PHARMASCIENCE INC
DIN 02016095 · ended Feb 8, 2018 · Disruption of the manufacture of the drug.
AvoidedPMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended May 10, 2017 · Disruption of the manufacture of the drug.
DiscontinuedAPO-LOPERAMIDE - TAB 2MG
2MG · TABLET · APOTEX INC
DIN 02212005
What's happening
Loperamide is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Loperamide is classified under “ANTIPROPULSIVES” (ATC A07DA).
Recent changes
Common questions
When will Loperamide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Loperamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.